Bowen Hanes & Co’s Sanofi SNY Stock Holding History

Bowen Hanes & Co’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-5,850	Closed	-$291K	–	145
2017 Q3	$291K	Buy	+5,850	New	+$283K	0.01%	134
2014 Q4	–	Sell	-231,130	Closed	-$13M	–	149
2014 Q3	$13M	Buy	+231,130	New	+$12.4M	0.64%	81

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bowen Hanes & Co's SNY Position: Q4 2017 in Review

Bowen Hanes & Co sold out of Sanofi (SNY) in Q4 2017, closing a stake of 5,850 shares — an estimated $291K sold.

Bowen Hanes & Co first reported a position in SNY in Q3 2014 and held it in 2 quarters. The position peaked at $13M in Q3 2014. 504 funds tracked by Wall St. Rank hold SNY as of Q4 2017.

Bowen Hanes & Co reported no remaining Sanofi position as of Q4 2017 after selling out during the quarter.
Bowen Hanes & Co sold 5,850 Sanofi shares in Q4 2017, an estimated $291K.
Bowen Hanes & Co first reported a position in Sanofi in Q3 2014 and held it in 2 quarters.
Bowen Hanes & Co's Sanofi position peaked at $13M in Q3 2014.
504 funds tracked by Wall St. Rank held Sanofi as of Q4 2017.

Based on Bowen Hanes & Co's 13F filing for Q4 2017, filed 13 Feb 2018.